Literature DB >> 33363652

PLASMA INTERLEUKIN-6 LEVELS MAY BE ASSOCIATED WITH THE LENGTH OF STAY TIME OF ADULT HYPERGLYCEMIC PATIENTS IN AN INTENSIVE CARE UNIT.

E Uysal1, Y A Acar2, R Celik3, N Nasuhbeyoglu4.   

Abstract

CONTEXT: Estimation of intensive care unit (ICU) length of stay time (LOS) may be challenging, and pro-inflammatory cytokines can be used as a marker for this purpose.
OBJECTIVE: The current study aimed to investigate the association between pro-inflammatory cytokine levels and LOS in hyperglycemic patients admitted to adult ICU.
DESIGN: This is a prospective observational study. SUBJECTS AND METHODS: All adult ICU patients with a blood glucose level higher than 250 mg/dL, during the study period were included. Hospitalization day demographics were recorded, and plasma IL-6, IL1-ß, and TNF-α concentrations were measured.
RESULTS: A total of 74 patients were enrolled in the study. Diabetic ketoacidosis (DKA) was positive in 31 patients, and the remaining 43 were in the non-DKA (NDKA) group. There was no difference between the two groups in terms of age, gender, LOS, hemoglobin, hematocrit, lactate levels, and platelets count. IL-6, IL-1ß, and TNF-α levels did not show any difference between DKA and NDKA groups (p=0.784, 0.413, and 0.288, respectively). There was a positive correlation between IL-6 levels and LOS (n=74, Pearson correlation=0.330; p=0.004).
CONCLUSIONS: Among pro-inflammatory cytokines, IL-6 showed a better performance for the prediction of LOS than IL-1ß, TNF-α, and CRP. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  Cytokine; Hyperglycemia; Intensive care unit; Interleukin-6; Length of stay time

Year:  2020        PMID: 33363652      PMCID: PMC7748229          DOI: 10.4183/aeb.2020.311

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  29 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Cytokine response to diabetic ketoacidosis and its treatment.

Authors:  William H Hoffman; C Lynne Burek; Jennifer L Waller; Lyle E Fisher; Mahmood Khichi; Larry B Mellick
Journal:  Clin Immunol       Date:  2003-09       Impact factor: 3.969

3.  Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM).

Authors:  Kyriaki Karavanaki; Evangelia Karanika; Soultana Georga; Anastasia Bartzeliotou; Manolis Tsouvalas; Ilias Konstantopoulos; Aspasia Fotinou; Ioannis Papassotiriou; Christina Karayianni
Journal:  Endocr J       Date:  2011-10-28       Impact factor: 2.349

4.  Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes.

Authors:  J C Pickup; G D Chusney; S M Thomas; D Burt
Journal:  Life Sci       Date:  2000-06-08       Impact factor: 5.037

5.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.

Authors:  P A Kern; S Ranganathan; C Li; L Wood; G Ranganathan
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-05       Impact factor: 4.310

6.  Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises.

Authors:  Frankie B Stentz; Guillermo E Umpierrez; Ruben Cuervo; Abbas E Kitabchi
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

7.  Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.

Authors:  Toralph Ruge; J Andrew Lockton; Frida Renstrom; Theodore Lystig; Valentina Sukonina; Maria K Svensson; Jan W Eriksson
Journal:  Metabolism       Date:  2009-06       Impact factor: 8.694

8.  Interleukin 6 and its receptor in the immune response and hematopoiesis.

Authors:  T Hirano; T Taga; T Matsuda; M Hibi; S Suematsu; B Tang; M Murakami; T Kishimoto
Journal:  Int J Cell Cloning       Date:  1990-01

9.  Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.

Authors:  Giovanni Davì; Francesco Chiarelli; Francesca Santilli; Mariapina Pomilio; Sergio Vigneri; Angela Falco; Stefania Basili; Giovanni Ciabattoni; Carlo Patrono
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

10.  Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia.

Authors:  William W Siljan; Jan C Holter; Ståle H Nymo; Einar Husebye; Thor Ueland; Pål Aukrust; Tom E Mollnes; Lars Heggelund
Journal:  Eur J Clin Invest       Date:  2017-12-07       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.